Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial

Sofia Pazmino*, Annelies Boonen, Veerle Stouten, Diederik De Cock, Johan Joly, Kristien Van der Elst, Rene Westhovens, Patrick Verschueren

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)556-565
Number of pages10
JournalAnnals of the Rheumatic Diseases
Volume79
Issue number5
DOIs
Publication statusPublished - May 2020

Keywords

  • MODIFYING ANTIRHEUMATIC DRUGS
  • TREATMENT STRATEGIES
  • MULTIPLE IMPUTATION
  • CLINICAL-TRIALS
  • DISEASE
  • METHOTREXATE
  • COMBINATION
  • EQ-5D
  • QUESTIONNAIRE
  • UTILITIES

Cite this